Elevation Oncology
Latest round
- Series B
Last raised
- Nov 2020
Total raised
- $98M
Investors
- 11
About Elevation Oncology
Elevation Oncology, Inc.Founded in 2019 and headquartered in New York, US, Elevation Oncology, Inc. focuses on developing targeted therapies for cancer.Elevation Oncology specializes in precision oncology, delivering groundbreaking therapeutics aimed at treating specific cancer profiles based on genetic mutations. Their portfolio includes a range of targeted therapies that cater to patients with various types of cancer, ensuring tailored treatment options.The company's revenue model is based on B2B transactions through subscription agreements for their therapeutic products. Clients typically enter into service agreements that include annual subscriptions or tiered pricing options for accessing the company's therapies.In June 2021, Elevation Oncology, Inc.25 million shares at USD 16 each on the NASDAQ. The company aims to introduce new products targeting additional oncogenic drivers and is strategically planning to expand into European and Asian markets by 2023.
Who invested in Elevation Oncology
11 investors across 2 rounds
See all investors in Elevation Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elevation Oncology
Who invested in Elevation Oncology?
Elevation Oncology has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elevation Oncology raised?
Elevation Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Elevation Oncology last raise money?
Elevation Oncology's most recent round on record is a Series B, in Nov 2020.
What does Elevation Oncology do?
Elevation Oncology is a biotechnology company.
Where is Elevation Oncology headquartered?
Elevation Oncology is headquartered in New York, US.
Which VCs invest in companies like Elevation Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elevation Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Elevation Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.